InvestorsHub Logo
Followers 0
Posts 202
Boards Moderated 0
Alias Born 05/02/2010

Re: None

Friday, 05/21/2010 10:21:40 AM

Friday, May 21, 2010 10:21:40 AM

Post# of 18784
From thestreet.com - Adam Feuerstein's Biotech Stock Mailbag, featuring AEZS and KERX

"I've received a lot of email in recent weeks echoing Jalil's comments suggesting Aeterna is under-valued relative to Keryx. If perifisone is a real drug and the phase III studies turn out positive, then the Aeterna bulls are right."

http://www.thestreet.com/story/10763051/3/biotech-stock-mailbag-amarin-pharma.html

I've always respected his opinions, regardless if I agreed or not. IMO, he writes in the best interest of the shareholders and not necessary the company.


Someone once said..."Don't dwell on unrealized profits"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News